Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction

Circulation Journal

Volumn 72, Issue 11, 2008, Pages 1836-1843

  Ueeda, Masayuki ^a   Doumei, Takenori ^a   Takaya, Yoichi ^a   Shinohata, Ryoko ^b   Katayama, Yusuke ^a   Ohnishi, Nobuhiko ^a   Takaishi, Atsushi ^a   Miyoshi, Toru ^c   Hirohata, Satoshi ^c   Kusachi, Shozo ^b  

^a Mitoyo General Hospital   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Coronary artery disease; Fatty acids; Infarction; Risk factors

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CALCIFICATION; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HOSPITAL ADMISSION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RISK FACTOR; SCORING SYSTEM;

AGED; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55449096036     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0249     Document Type: Article

References (40)

1. von Schacky C. n-3 fatty acids and the prevention of coronary atherosclerosis. Am J Clin Nutr 2000; 71: 224S-227S.
2. Bhatnagar D, Durrington PN. Omega-3 fatty acids: Their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 2003; 57: 305-314.
3. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-1098.
4. von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids: A comprehensive strategy. Ann Intern Med 1987; 107: 890-899.
5. Endres S, von Schacky C. n-3 polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 1996; 7: 48-52.
6. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271.
7. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
8. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J Lipid Res 1989; 30: 785-807.
9. Moreno JJ, Mitjavila MT. The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (Review). J Nutr Biochem 2003; 14: 182-195.
10. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.
11. Thieme T, Wernecke KD, Meyer R, Brandenstein E, Habedank D, Hinz A, et al. Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 1996; 28: 1-6.
12. Hodgson JM, Reddy KG, Suneja R, Nair RN, Lesnefsky EJ, Sheehan HM. Intracoronary ultrasound imaging: Correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol 1993; 21: 35-44.
13. Kato M, Dote K, Sasaki S, Ueda K, Matsuda O, Nakano Y, et al. Coronary plaque vulnerability in metabolic syndrome: Assessment of carotid artery morphology in acute coronary syndrome. Circ J 2007; 71: 1229-1233.
14. Okura H, Taguchi H, Kubo T, Toda I, Yoshida K, Yoshiyama M, et al. Atherosclerotic plaque with ultrasonic attenuation affects coronary reflow and infarct size in patients with acute coronary syndrome: An intravascular ultrasound study. Circ J 2007; 71: 648-653.
15. Kuettner A, Beck T, Drosch T, Kettering K, Heuschmid M, Burgstahler C, et al. Image quality and diagnostic accuracy of non-invasive coronary imaging with 16 detector slice spiral computed tomography with 188 ms temporal resolution. Heart 2005; 91: 938-941.
16. Hara T, Yamada S, Hayashi T, Ikeda Y, Yamashiro K, Mizutani K, et al. Accuracy of nonstenotic coronary atherosclerosis assessment by multi-detector computed tomography. Circ J 2007; 71: 911-914.
17. Komatsu S, Hirayama A, Omori Y, Ueda Y, Mizote I, Fujisawa Y, et al. Detection of coronary plaque by computed tomography with a novel plaque analysis system, 'Plaque Map', and comparison with intravascular ultrasound and angioscopy. Circ J 2005; 69: 72-77.
18. Schroeder S, Kuettner A, Leitritz M, Janzen J, Kopp AF, Herdeg C, et al. Reliability of differentiating human coronary plaque morphology using contrast-enhanced multislice spiral computed tomography: A comparison with histology. J Comput Assist Tomogr 2004; 28: 449-454.
19. Nakamura T, Azuma A, Kuribayashi T, Sugihara H, Okuda S, Nakagawa M. Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: The Kumihama study. Br J Nutr 2003; 89: 267-272.
20. Yli-Jama P, Meyer HE, Ringstad J, Pedersen JI. Serum free fatty acid pattern and risk of myocardial infarction: A case-control study. J Intern Med 2002; 251: 19-28.
21. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35: 2-3.
22. Ozawa T, Takayanagi K, Fujita T, Hirai A, Hamazaki T, Terano T, et al. Determination of long chain fatty acids in human total plasma lipids using gas chromatography. Bunseki Kagaku 1981; 31: 87-91 (in Japanese with English abstract).
23. Kaluzny MA, Duncan LA, Merritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 1985; 26: 135-140.
24. Folsh J, Lees M, Sloane M, Stanley G. A simple method for the isolation and purification of total lipids from animal tisues. J Biol Chem 1957; 226: 497-509.
25. Shantha NC, Ackman RG. Nervonic acid versus tricosanoic acid as internal standards in quantitative gas chromatographic analyses of fish oil longer-chain n-3 polyunsaturated fatty acid methyl esters. J Chromatogr 1990; 533: 1-10.
26. Hoshi M, Williams M, Kishimoto Y. Esterification of fatty acids at room temperature by chloroform-methanolic HCl-cupric acetate. J Lipid Res 1973; 14: 599-601.
27. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
28. Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002; 9: 1-27.
29. Stary HC. Natural history and histological classification of atherosclerotic lesions: An update. Arterioscler Thromb Vasc Biol 2000; 20: 1177-1178.
30. Crofts JW, Ogburn PL Jr, Johnson SB, Holman RT. Polyunsaturated fatty acids of serum lipids in myocardial infarction. Lipids 1988; 23: 539-545.
31. Gupta DK, Jewitt DE, Young R, Hartog M, Opie LH. Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet 1969; 2: 1209-1213.
32. Flink EB, Brick JE, Shane SR. Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 1981; 141: 441-443.
33. Hagenfeldt L, Wester PO. Plasma levels of individual free fatty acids in patients with acute myocardial infarction. Acta Med Scand 1973; 194: 357-362.
34. Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil: A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989; 320: 1037-1043.
35. Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: A population-based intervention trial from the Tromso study. N Engl J Med 1990; 322: 795-801.
36. Toft I, Bonaa KH, Ingebretsen OC, Nordoy A, Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: A randomized, controlled trial. Ann Intern Med 1995; 123: 911-918.
37. Riemersma RA, Wood DA, Butler S, Elton RA, Oliver M, Salo M, et al. Linoleic acid content in adipose tissue and coronary heart disease. BMJ (Clin Res Ed) 1986; 292: 1423-1427.
38. Oliver MF, Riemersma RA, Thomson M, Fulton M, Abraham RA, Wood DA. Linoleic acid and coronary heart disease. Br J Hosp Med 1989; 42: 298, 301-292.
39. Kondo T, Ogawa K, Satake T, Kitazawa M, Taki K, Sugiyama S, et al. Plasma-free eicosapentaenoic acid/arachidonic acid ratio: A possible new coronary risk factor. Clin Cardiol 1986; 9: 413-416.
40. Harris WS, Assaad B, Poston WC. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol 2006; 98: 19i-26i.